Court Grants Teva-Ivax Bid For Zocor Exclusivity
In a boon for Israeli generics maker Teva Pharmaceuticals Ltd., a federal court has ruled that its recent acquisition, Ivax Corp., should be granted 180 days of exclusivity to market a...To view the full article, register now.
Already a subscriber? Click here to view full article